logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
M

Mazyar Shadman

fred hutchinson cancer center

46H指数
567论文数
8.5K被引数
收录论文 107
发表时间
logo
Association between patient-reported symptoms and clinical outcomes in R/R CLLR/R CLL患者报告症状与临床结局之间的关联
errBlood Advances
IF7.1
err2026-09-17
err0
errOAAI
errTimothy Victor; Gisoo Barnes; Mazyar Shadman; Nicole Lamanna; Constantine S. Tam; Luigi Qiu; Tommi Salmi; Frederick B. Barnes; Rasika Korde; Jennifer R. Brown
err分享
err收藏
Barriers to Patient Referral and Completion of CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma复发/难治性大B细胞淋巴瘤患者接受CAR T细胞治疗转诊与完成过程中的障碍
errTransplantation and Cellular Therapy
IF4.4
err2026-09-09
err0
PREAI
errMazyar Shadman; Jenny Ahlstrom; Meghan Gutierrez; Loretta Nastoupil; David Porter; Ashley Schmitt; Laura Zitella; Tara Graff
err分享
err收藏
Real-world outcomes of bispecific antibody therapy after chimeric antigen receptor T-cell therapy in follicular lymphoma滤泡性淋巴瘤中，嵌合抗原受体T细胞疗法后双特异性抗体疗法的真实世界结局
errBlood Cancer Journal
IF11.6
err2026-06-18
err0
errOAAI
errJohn Sharp; Subodh Bhatta; Jennifer J. Huang; Colin J. Thomas; Omar Elghawy; Lindsey Fitzgerald; Daniel Reef; Andinet Teferra; Timothy J. Voorhees; Supriya Gupta; Natalie S. Grover; Stefan K. Barta; Mazyar Shadman; Narendranath Epperla
err分享
err收藏
Indirect Comparison of the Efficacy of Zanubrutinib vs Ibrutinib and Acalabrutinib in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-Up治疗初治慢性淋巴细胞白血病的泽布替尼与伊布替尼、阿卡替尼疗效的间接比较：6年随访
errAdvances in Therapy
IF4
err2026-06-11
err0
errOAAI
errMazyar Shadman; Talha Munir; Sheng Xu; Keri Yang; Leyla Mohseninejad; Grace Guthrie; Jamie Hirata; Marcus Lefebure; Rhys Williams; Constantine S. Tam
err分享
err收藏
Five-year survival outcomes of lisocabtagene maraleucel in R/R LBCL from the TRANSCEND NHL 001 studylisocabtagene maraleucel在TRANSCEND NHL 001研究中复发/难治性LBCL的五年生存结局
errBlood
IF23.1
err2026-06-05
err0
errOAAI
errJeremy S. Abramson; Tanya Siddiqi; Leo I. Gordon; Matthew Lunning; Michael Wang; Jon Arnason; Manali Kamdar; David G. Maloney; Mazyar Shadman; Charalambos Andreadis; Alison Sehgal; Scott R. Solomon; Nilanjan Ghosh; Juliana E. Hidalgo-López; Jing Wang; Xue Ding; Ken Ogasawara; Ashvin Singh; M. Lia Palomba
err分享
err收藏
Early neurologic response predicts outcomes after anakinra for immune effector cell-associated neurotoxicity syndrome早期神经系统反应预测anakinra治疗免疫效应细胞相关神经毒性综合征的结局
errBlood Advances
IF7.1
err2026-06-02
err0
errOAAI
errEmily C. Liang; Smith Kungwankiattichai; Xiancheng Wu; Jenna Voutsinas; Dwight Macero; Christy Khouderchah; Yang Qiao; Yein Jeon; Ryan Basom; Jennifer J. Huang; Andrew J. Portuguese; Erik L. Kimble; Alexandre V. Hirayama; Mazyar Shadman; Andy I. Chen; Amrita Desai; Brandon Hayes-Lattin; Gabrielle Meyers; Sanjog Bastola; Manoj Rai
err分享
err收藏
Prolonged progression-free survival with zanubrutinib in relapsed/refractory CLL: an indirect treatment comparison versus other BTK inhibitors using multilevel network meta-regression奥布替尼在复发/难治性慢性淋巴细胞白血病中的延长无进展生存期：与其他BTK抑制剂的多水平网络Meta回归间接治疗比较
errJournal of Medical Economics
IF3
err2026-05-23
err0
errOAAI
errShadman, Mazyar; Bouwmeester, Walter; Mohseninejad, Leyla; Xu, Sheng; Jevdjevic, Milica; Yang, Keri; Williams, Rhys; Jansen, Jeroen P.
err分享
err收藏
“Immunologic Dream Team”: BiTEs peri-allotransplant to redirect donor lymphocytes towards GVL“免疫学梦之队”：移植后供者淋巴细胞导向GVL的BiTEs
errBlood Advances
IF7.1
err2026-05-22
err0
errOAAI
errLorenzo Iovino; Mazyar Shadman; Filippo Milano; Ajay K. Gopal
err分享
err收藏
A Comprehensive Review of the Role of Zanubrutinib for Patients with Chronic Lymphocytic LeukemiaBruton酪氨酸激酶抑制剂佐那布替尼在慢性淋巴细胞白血病治疗中的角色综述
errOncology and Therapy
IF3.2
err2026-05-14
err0
errOAAI
errPaolo Ghia; Jennifer R. Brown; Mazyar Shadman; Clemens-Martin Wendtner
err分享
err收藏
Real-world outcomes for lisocabtagene maraleucel in patients with relapsed or refractory large B-cell lymphoma利萨库肽马瑞卢赛尔在复发或难治性大B细胞淋巴瘤患者中的真实世界结局
errBlood
IF23.1
err2026-03-05
err0
errOAAI
errJennifer L. Crombie; Sairah Ahmed; Matthew J. Frigault; Bradley D. Hunter; M. Lia Palomba; Abu-Sayeef Mirza; Matthew Lunning; Ogechukwu Egini; Maria Silvina Odstrcil Bobillo; Avyakta Kallam; Swetha Kambhampati Thiruvengadam; Dasom C. Lee; Saurabh Dahiya; Mehdi Hamadani; Alex F. Herrera; Catherine J. Lee; Krish Patel; Sagar S. Patel; Patrick M. Reagan; Mazyar Shadman
err分享
err收藏
Number needed to treat to avoid progression and death and cost analysis: zanubrutinib versus acalabrutinib in relapsed/refractory chronic lymphocytic leukemia需要治疗以避免进展和死亡的数量和成本分析: zanubrutinib与acalabrutinib在复发/难治性慢性淋巴细胞白血病中的比较
errFuture Oncology
IF2.6
err2026-01-31
err0
PREAI
errMazyar Shadman; Asher Chanan-Khan; David Campbell; Mei Xue; Marjan Massoudi; Rhys Williams; Keri Yang; Constantine S. Tam
err分享
err收藏
Epcoritamab monotherapy for Richter transformation (EPCORE CLL-1): findings from a single-arm, multicentre, open-label, phase 1b/2 trialEpcoritamab单药治疗Richter转化（EPCORE CLL-1）：一项单臂、多中心、开放标签的Ⅰb/Ⅱ期试验结果
errThe Lancet Haematology
IF0
err2025-12-08
err0
PREAI
errArnon P Kater; Ann Janssens; Herbert Eradat; Fritz Offner; Jose D Sandoval-Sus; Mazyar Shadman; Christian Bjørn Poulsen; Jacob Haaber Christensen; Meghan C Thompson; Meijian Guan; Andrew J Steele; Marcia Rios; Marie Holst Mørch; Toshihiko Oki; Rebecca Valentin; Mar Bellido; Barbara Eichhorst
err分享
err收藏
Real-world treatment patterns and clinical outcomes among patients with diffuse large B-cell lymphoma in a US healthcare claims database美国医疗索赔数据库中弥漫性大B细胞淋巴瘤患者的真实世界治疗模式与临床结局
errBlood Cancer Journal
IF11.6
err2025-12-05
err0
errOAAI
errMazyar Shadman; Jennifer S. Harper; Alex Bokun; Chang Xu; Pei Lin; Gloria Graf; Xiaoxiao Lu
err分享
err收藏
Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trial微小残留病灶状态可预测接受化疗免疫疗法治疗的滤泡性淋巴瘤患者的结局（SWOG S0016试验）。
errHAEMATOLOGICA
IF7.9
err2025-12-01
err0
errOAAI
errDanilov, Alexey, V; Li, Hongli; Shadman, Mazyar; Rimsza, Lisa; Zebari, Ahmad; Smith, Sonali M.; LeBlanc, Michael; Friedberg, Jonathan W.; Carlson, Christopher; Song, Joo Y.
err分享
err收藏
Extramedullary disease is associated with severe toxicities following B-cell maturation antigen CAR T-cell therapy in multiple myeloma髓外疾病与多发性骨髓瘤中B细胞成熟抗原CAR T细胞疗法后的严重毒性与相关。
errHAEMATOLOGICA
IF7.9
err2025-12-01
err5
errOAAI
errPortuguese, Andrew J.; Liang, Emily C.; Huang, Jennifer J.; Jeon, Yein; Dima, Danai; Banerjee, Rahul; Kwok, Mary; Cicero, Kara I.; Hirayama, Alexandre, V; Basom, Ryan; Khouderchah, Christy; Shadman, Mazyar; Fong, Lawrence; Cowan, Andrew J.; Gauthier, Jordan
err分享
err收藏
Bispecific antibodies in action: the reality of engagement双特异性抗体在行动：结合的真实情况
errBlood
IF23.1
err2025-10-30
err0
PREAI
errMazyar Shadman; Ajay K. Gopal
err分享
err收藏
Who Is Eligible for CAR T-Cell Therapy? Expert Perspectives on Overcoming Referral Barriers谁有资格接受CAR T细胞疗法？专家视角：克服转诊障碍
errTransplantation and Cellular Therapy
IF4.4
err2025-10-23
err0
PREAI
errMazyar Shadman; Sairah Ahmed; Michael T. Byrne; Julio C. Chavez; Manali Kamdar; Mohamed L. Sorror; Miguel-Angel Perales; Joshua A. Hill; Javid Moslehi; David B. Miklos
err分享
err收藏
Total Body Irradiation Versus Chemotherapy-Only Conditioning in Autologous Hematopoietic Stem Cell Transplantation for relapsed/refractory Large B-Cell Lymphoma自体造血干细胞移植治疗复发/难治性大B细胞淋巴瘤中全身照射与单纯化疗预处理方案的比较
errClinical Oncology
IF3
err2025-10-14
err0
PREAI
errMaryam Ebadi; Xinyi Fan; Gary Schoch; Ted Gooley; Armin Rashidi; Stephen D. Smith; Mazyar Shadman; Leona Holmberg; Chaitra Ujjani; Christina Poh; Vikram Raghunathan; Naveed Ali; Phuong T. Vo; Shivaprasad Manjappa; Manoj Menon; Mengyang Di; Ryan Lynch; Carrie Ho; Brian G. Till; Ralph Ermoian; Ajay K. Gopal; Yolanda D. Tseng
err分享
err收藏
First-line Therapy Time-Limited Venetoclax Doublet Therapy一线治疗时间限制性Venetoclax双药疗法
errHEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
IF2.7
err2025-10-01
err0
PREAI
errHuang, Jennifer; Shadman, Mazyar
err分享
err收藏
Development and Validation of a Gene Expression Signature to Predict Early Events in Patients with Follicular Lymphoma开发和验证一种用于预测滤泡性淋巴瘤患者早期事件的基因表达谱
errBlood Advances
IF7.1
err2025-09-22
err0
errOAAI
errColleen A. Ramsower; George Wright; Hongli Li; James R. Cerhan; Matthew J. Maurer; Raphael Mwangi; Allison C. Rosenthal; Anne J. Novak; Brian K. Link; Thomas E. Witzig; Thomas M. Habermann; Robert Kridel; Michael R. LeBlanc; Mazyar Shadman; Sonali M. Smith; Jonathan W. Friedberg; David W. Scott; Christian Steidl; Louis M. Staudt; Lisa M. Rimsza
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
M
Meletios Α. Dimopoulos
H 指数: 159 · 论文数: 3.0K
L
Louis M. Staudt
H 指数: 145 · 论文数: 802
A
Andrea Natale
H 指数: 136 · 论文数: 2.1K
T
Thomas E. Witzig
H 指数: 129 · 论文数: 1.3K
M
Michael Hallek
H 指数: 124 · 论文数: 1.6K
查看更多